Skip to main content
SpringerLink
Log in

Gene Therapy Using Encapsulated Cells

  • Chapter
Applications of Cell Immobilisation Biotechnology

Part of the book series: Focus on Biotechnology ((FOBI,volume 8B))

  • 1594 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chang, T.M.S. (1997) Artificial cells and bioencapsulation in bioartificial organs. Ann. NY Acad Sci. 831: 249–259.

    Article  PubMed  CAS  Google Scholar 

  2. Huang, J.; Pray, C. and Rozelle, S. (2002) Enhancing the crops to feed the poor. Nature 418(6898): 678–684.

    Article  PubMed  CAS  Google Scholar 

  3. Vajo, Z.; Fawcett, J. and Duckworth, W.C. (2001) Recombinant DNA technology in the treatment of diabetes: insulin analogs. Endocr. Rev. 22(5): 706–717.

    Article  PubMed  CAS  Google Scholar 

  4. Mannucci, P.M. and Giangrande, P.L. (2000) Choice of replacement therapy for hemophilia: recombinant products only? Hematol. J. 1(2): 72–76.

    Article  PubMed  CAS  Google Scholar 

  5. Anderson, W.F.; Blaese, R.M., and Culver, K. (1990) The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990. Hum Gene Ther. 1(3): 331–362.

    Article  PubMed  Google Scholar 

  6. Teichler Zallen, D. (2000) US gene therapy in crisis. Trends Genet. 16(6): 272–275.

    Article  PubMed  CAS  Google Scholar 

  7. Cavazzana-Calvo, M.; Hacein-Bey, S.; de Saint Basile, G.; Gross, F.; Yvon, E.; Nusbaum, P.; Selz, F.; Hue, C.; Certain, S.; Casanova, J.L.; Bousso, P.; Deist, F.L. and Fischer, A. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288(5466): 669–672.

    Article  PubMed  CAS  Google Scholar 

  8. Ledley, F.D. (1995) Hepatic gene therapy. In Chang, P.L. (Ed.) Somatic gene therapy, CRC Press, pp. 61–72.

    Google Scholar 

  9. Lotze, M.T. and Kost, T.A. (2002) Viruses as gene delivery vectors: application to gene function, target validation, and assay development. Cancer Gene Ther. 9(8): 692–699.

    Article  PubMed  CAS  Google Scholar 

  10. Marshall, E. (2001a) Gene therapy. Viral vectors still pack surprises. Science 294: 1640.

    Article  PubMed  CAS  Google Scholar 

  11. Marshall, E. (2001b) Gene therapy. Panel reviews risks of germ line changes. Science 294: 2268–2269.

    Google Scholar 

  12. Lechardeur, D. and Lukacs, G.L. (2002) Intracellular barriers to non-viral gene transfer. Curr Gene Ther 2(2): 183–194.

    Article  PubMed  CAS  Google Scholar 

  13. Matthews, C.; Jenkins, G.; Hilfinger, J. and Davidson, B. (1999) Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres. Gene Ther. 6(9): 1558–1564.

    Article  PubMed  CAS  Google Scholar 

  14. Sailaja, G.; HogenEsch, H.; North, A.; Hays, J. and Mittal, S.K. (2002) Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response. Gene Ther. 9(24): 1722–1729.

    Article  PubMed  CAS  Google Scholar 

  15. Hortelano, G.; Xu, N.; Vandenberg, A.; Solera, J.; Chang, P.L. and Ofosu, F.A. (1999) Persistent delivery of factor IX in mice: Gene therapy for hemophilia B using implantable microcapsules. Human Gene Ther. 10(8): 1281–1288.

    Article  CAS  Google Scholar 

  16. Qin, L.; Ding, Y.; Pahud, D.R.; Chang, E.; Imperiale, M.J. and Bromberg, J.S. (1997) Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther. 8(17): 2019–2029.

    PubMed  CAS  Google Scholar 

  17. Buchschacher, G.L. Jr. (2001) Introduction to retroviruses and retroviral vectors. Somat. Cell Mol. Genet. 26(1–6): 1–11.

    Article  PubMed  Google Scholar 

  18. Pannell, D. and Ellis, J. (2001) Silencing of gene expression: implications for design of retrovirus vectors. Rev. Med. Virol. 11(4): 205–217.

    Article  PubMed  CAS  Google Scholar 

  19. Marshall, E. (2002) Gene Therapy a Suspect in Leukemia-like Disease. Science 298: 34–35.

    Article  PubMed  CAS  Google Scholar 

  20. Yee, J.K. and Zaia, J.A. (2001) Prospects for gene therapy using HIV-based vectors. Somat. Cell Mol. Genet. 26(1–6): 159–174.

    Article  PubMed  CAS  Google Scholar 

  21. Breyer, B.; Jiang, W.; Cheng, H.; Zhou, L.; Paul, R.; Feng, T. and He, T.C. (2001) Adenoviral vectormediated gene transfer for human gene therapy. Curr. Gene Ther. 1(2): 149–162.

    Article  PubMed  CAS  Google Scholar 

  22. Trudel, S.; Li, Z., Dodgson, C.; Nanji, S.; Wan, Y.; Voralia, M.; Hitt, M.; Gauldie, J.; Graham, F.L. and Stewart, A.K. (2001) Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma—a phase 1 study. Leukemia 15(5): 846–854.

    Article  PubMed  CAS  Google Scholar 

  23. DelloRusso, C.; Scott, J.M.; Hartigan-O’Connor, D.; Salvatori, G.; Barjot, C.; Robinson, A.S.; Crawford, R.W.; Brooks, S.V. and Chamberlain J.S. (2002) Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proc. Natl. Acad. Sci. USA 99(20): 12979–12984.

    Article  PubMed  CAS  Google Scholar 

  24. Kochanek, S.; Schiedner, G. and Volpers, C. (2001) High-capacity ‘gutless’ adenoviral vectors. Curr. Opin. Mol. Ther. 3(5): 454–463.

    PubMed  CAS  Google Scholar 

  25. Balague, C.; Zhou, J.; Dai, Y.; Alemany, R.; Josephs, S.F.; Andreason, G.; Hariharan, M.; Sethi, E. Prokopenko, E.; Jan, H.Y.; Lou, Y.C.; Hubert-Leslie, D.; Ruiz, L. and Zhang, W.W. (2000) Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. Blood 95(3): 820–828.

    PubMed  CAS  Google Scholar 

  26. Owens, R.A. (2002) Second generation adeno-associated virus type 2-based gene therapy systems with the potential for preferential integration into AAVS1. Curr. Gene Ther. 2(2): 145–159.

    Article  PubMed  CAS  Google Scholar 

  27. Kay, M.A.; Manno, C.S.; Ragni, M.V.; Larson, P.J.; Couto, L.B.; McClelland, A.; Glader, B.; Chew, A.J.; Tai, S.J.; Herzog, R.W.; Arruda, V.; Johnson, F.; Scallan, C.; Skarsgard, E.; Flake, A.W. and High, K.A. (2000) Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat. Genet. 24(3): 257–261.

    Article  PubMed  CAS  Google Scholar 

  28. Lilley, C.E.; Branston, R.H. and Coffin, R.S. (2001) Herpes simplex virus vectors for the nervous system. Curr. Gene Ther. 1(4): 339–358.

    Article  PubMed  CAS  Google Scholar 

  29. Somiari, S.; Glasspool-Malone, J.; Drabick, J.J.; Gilbert, R.A.; Heller, R.; Jaroszeski, M.J. and Malone, R.W. (2000) Theory and in vivo application of electroporative gene delivery. Mol. Ther. 2(3): 178–187.

    Article  PubMed  CAS  Google Scholar 

  30. Lin, M.T.; Pulkkinen, L.; Uitto, J. and Yoon, K. (2000) The gene gun: current applications in cutaneous gene therapy. Int. J. Dermatol. 39(3): 161–170.

    Article  PubMed  CAS  Google Scholar 

  31. Brauker, J.; Frost, G.H.; Dwarki, V.; Nijjar, T.; Chin, R.; Carr-Brendel, V.; Jasunas, C.; Hodgett, D., Stone, W.; Cohen, L.K.; and Johnson, R.C. (1998) Sustained expression of high levels of human factor IX from human cells implanted within an immunoisolation device into athymic rodents. Hum. Gene Ther. 9(6): 879–888.

    PubMed  CAS  Google Scholar 

  32. Hortelano, G.; Al-Hendy, A.; Ofosu, F.A. and Chang, P.L. (1996) Delivery of human factor IX in mice by microencapsulated recombinant myoblasts: A novel approach towards allogeneic gene therapy of hemophilia B. Blood 87(12): 5095–5103.

    PubMed  CAS  Google Scholar 

  33. Hortelano, G.; Wang, L.; Xu, N. and Ofosu, F.A. (2001) Sustained and therapeutic delivery of human factor IX in nude hemophilia B mice implanted by encapsulated C2C12 myoblasts: concurrent tumorigenesis. Haemophilia 7(2): 207–213.

    Article  PubMed  CAS  Google Scholar 

  34. Liu, H.W.; Ofosu, F.A. and Chang, P.L. (1993) Expression of human factor IX by microencapsulated recombinant fibroblasts. Hum Gene Ther. 4(3): 291–301.

    PubMed  CAS  Google Scholar 

  35. Hughes, M.; Vassilakos, A.; Andrews, D.W.; Hortelano, G.; Belmont, J.W. and Chang, P.L. (1994) Delivery of a secretable adenosine deaminase through microcapsules — a novel approach to somatic gene therapy. Hum Gene Ther. 5(12): 1445–1455.

    PubMed  CAS  Google Scholar 

  36. Al-Hendy, A.; Hortelano, G.; Tannenbaum, G.S. and Chang, P.L. (1995) Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts — an alternate approach to somatic gene therapy. Hum Gene Ther. 6(2): 165–175.

    PubMed  CAS  Google Scholar 

  37. Ross, C.J.; Bastedo, L.; Maier, S.A.; Sands, M.S. and Chang, P.L. (2000) Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells. Hum Gene Ther. 11(15): 2117–2127.

    Article  PubMed  CAS  Google Scholar 

  38. Chang, P.L.; Van Raamsdonk, J.M.; Hortelano, G.; Barsoum, S.C.; MacDonald, N.C. and Stockley, T.L. (1999) The in vivo delivery of heterologous proteins by microencapsulated recombinant cells. Trends Biotechnol. 17(2): 78–83.

    Article  PubMed  CAS  Google Scholar 

  39. Goto, S.; Miyazaki, K.; Funabiki, T. and Yasumitsu, H. (1999) Serum-free culture conditions for analysis of secretory proteinases during myogenic differentiation of mouse C2C12 myoblasts. Anal. Biochem. 272(2): 135–142.

    Article  PubMed  CAS  Google Scholar 

  40. Gunning, P.; Leavitt, J.; Muscat, G.; Ng, S.Y. and Kedes L. (1987) A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 84(14): 4831–4835.

    PubMed  CAS  Google Scholar 

  41. Rinsch, C.; Dupraz, P.; Schneider, B.L.; Deglon, N.; Maxwell, P.H.; Ratcliffe, P.J.; Aebischer, P. (2002) Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia. Kidney Int. 62(4): 1395–1401.

    Article  PubMed  CAS  Google Scholar 

  42. Springer, M.L.; Hortelano, G.; Bouley, D.; Kraft, P.E.; Wong, J. and Blau, H.M. (2000) Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor. J. Gene Med. 2(4): 279–288.

    Article  PubMed  CAS  Google Scholar 

  43. Rinsch, C.; Peduto, G.; Schneider, B.L. and Aebischer, P. (2001) Inducing host acceptance to encapsulated xenogeneic myoblasts. Transplantation 71(3): 345–351.

    Article  PubMed  CAS  Google Scholar 

  44. Aebischer, P.; Schluep, M.; Deglon, N.; Joseph, J.M.; Hirt, L.; Heyd, B.; Goddard, M.; Hammang, J.P.; Zurn, A.D.; Kato, A.C.; Regli, F. and Baetge, E.E. (1996) Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 2(6): 696–699.

    Article  PubMed  CAS  Google Scholar 

  45. Buchser, E.; Goddard, M.; Heyd, B.; Joseph, J.M.; Favre, J.; de Tribolet, N.; Lysaght, M. and Aebischer, P. (1996) Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience. Anesthesiology 85(5): 1005–1012.

    Article  PubMed  CAS  Google Scholar 

  46. Piskin, E. (2002). Biodegradable polymeric matrices for bioartificial implants. Int. J. Artif. Organs 25(5): 434–440.

    PubMed  CAS  Google Scholar 

  47. Cirone, P.; Bourgeois, J.M.; Austin, R.C. and Chang, P.L. (2002). A novel approach to tumor suppression with microencapsulated recombinant cells. Hum. Gene Ther. 13(10): 1157–1166.

    Article  PubMed  CAS  Google Scholar 

  48. Read, T.A.; Sorensen, D.R.; Mahesparan, R.; Enger, P.O.; Timpl, R.; Olsen, B.R.; Hjelstuen, M.H.; Haraldseth, O. and Bjerkvig, R. (2001) Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat. Biotechnol. 19(1): 29–34.

    Article  PubMed  CAS  Google Scholar 

  49. Muller, P.; Jesnowski, R.; Karle, P.; Renz, R.; Saller, R.; Stein, H.; Puschel, K.; von Rombs, K.; Nizze, H.; Liebe, S.; Wagner, T.; Gunzburg, W.H.; Salmons, B. and Lohr, M. (1999) Injection of encapsulated cells producing an ifosfamide-activating cytochrome P450 for targeted chemotherapy to pancreatic tumors. Ann. NY Acad. Sci. 880: 337–351.

    Article  PubMed  CAS  Google Scholar 

  50. Lohr, M.; Hummel, F.; Faulmann, G.; Ringel, J.; Saller, R.; Hain, J.; Gunzburg, W.H. and Salmons, B. (2002) Microencapsulated, CYP2B1-transfected cells activating ifosfamide at the site of the tumor: the magic bullets of the 21st century. Cancer Chemother. Pharmacol. 49Suppl. 1: S21–24.

    PubMed  CAS  Google Scholar 

  51. Lohr, M.; Hoffmeyer, A.; Kroger, J.; Freund, M.; Hain, J.; Holle, A.; Karle, P.; Knofel, W.T.; Liebe, S.; Muller, P.; Nizze, H.; Renner, M.; Saller, R.M.; Wagner, T.; Hauenstein, K.; Gunzburg, W.H. and Salmons, B. (2001) Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet 357(9268): 1591–1592.

    Article  PubMed  CAS  Google Scholar 

  52. Geller, R.L.; Neuenfeldt, S.; Levon, S.A.; Maryanov, D.A.; Thomas, T.J. and Brauker, J.H. (1997) Immunoisolation of tumor cells: generation of antitumor immunity through indirect presentation of antigen. J. Immunother. 20(2): 131–137.

    Article  PubMed  CAS  Google Scholar 

  53. Huber, A.; Padrun, V.; Deglon, N.; Aebischer, P.; Mohler, H. and Boison, D. (2001) Grafts of adenosinereleasing cells suppress seizures in kindling epilepsy. Proc. Natl. Acad. Sci. USA 98(13): 7611–7616.

    Article  PubMed  CAS  Google Scholar 

  54. Deglon, N.; Heyd, B.; Tan, S.A.; Joseph, J.M.; Zurn, A.D. and Aebischer, P. (1996) Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts. Hum. Gene Ther. 7(17): 2135–2146.

    PubMed  CAS  Google Scholar 

  55. Zurn, A.D.; Widmer, H.R. and Aebischer, P. (2001) Sustained delivery of GDNF: towards a treatment for Parkinson’s disease. Brain Res. Rev. 36(2–3): 222–229.

    Article  PubMed  CAS  Google Scholar 

  56. Zurn, A.D.; Henry, H.; Schluep, M.; Aubert, V.; Winkel, L.; Eilers, B.; Bachmann, C. and Aebischer, P. (2000) Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells. Cell Transplant. 9(4): 471–484.

    PubMed  CAS  Google Scholar 

  57. Emerich, D.F.; Cain, C.K.; Greco, C.; Saydoff, J.A.; Hu, Z.Y.; Liu, H. and Lindner, M.D. (1997) Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington’s disease. Cell Transplant. 6(3): 249–266.

    Article  PubMed  CAS  Google Scholar 

  58. Saitoh, Y.; Eguchi, Y.; Hagihara, Y.; Arita, N.; Watahiki, M.; Tsujimoto, Y. and Hayakawa, T. (1998) Dose-dependent doxycycline-mediated adrenocorticotropic hormone secretion from encapsulated Tet-on proopiomelanocortin Neuro2A cells in the subarachnoid space. Hum. Gene Ther. 9(7): 997–1002.

    PubMed  CAS  Google Scholar 

  59. Sommer, B.; Rinsch, C.; Payen, E.; Dalle, B.; Schneider, B.; Deglon, N.; Henri, A.; Beuzard, Y. and Aebischer, P. (2002). Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts. Mol. Ther. 6(2): 155–161.

    Article  PubMed  CAS  Google Scholar 

  60. Dalle, B.; Payen, E.; Regulier, E.; Deglon, N.; Rouyer-Fessard, P.; Beuzard, Y. and Aebischer, P. (1999) Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts. Gene Ther. 6(2): 157–161.

    Article  PubMed  CAS  Google Scholar 

  61. Hedner, U. and Davie, E.W. (1989) Introduction to hemostasis and the vitamin K-dependent coagulation factors. In Scriver, C.R.; Beaudet, A.L.; Sly, W.S. and Valle, D. (Eds.) The metabolic basis of inherited disease, vol. II, 6th edition, McGraw-Hill, New York; pp. 2107.

    Google Scholar 

  62. Gianelli, F; Green, P.M.; High, K.A.; Sommer, S.; Poon, M.C.; Ludwig, M., Schwaab, R.; Reitsma, P.H.; Goossens, M. and Yoshioka, A. (1993) Haemophilia B: database of point mutations and short additions and deletions-third edition. Nucleic Acids Res. 21: 3075–3087.

    Google Scholar 

  63. Roberts, H.R. and Eberst, M.E. (1993) Current management of hemophilia B. Hematology/Oncology clinics of North America 7(6): 1269–1279.

    PubMed  CAS  Google Scholar 

  64. Walker, I. (1997) Recombinant factor IX has been licensed for use. Hemophilia Today (Summer).

    Google Scholar 

  65. Kay, M.A.; Rothenberg, S.; Landen, C.N.; Bellinger, D.A.; Leland, F.; Toman, C.; Finegold, M.; Thompson, A.R.; Read, M.S.; Brinkhous, K.M.; et al. (1993). In vivo gene therapy for hemophilia B: Sustained partial correction in factor IX deficient dogs. Science 262: 117–119.

    PubMed  CAS  Google Scholar 

  66. Bi, L.; Lawler, A.M.; Antonarakis, S.E.; High, KA; Gearhart, JD and Kazazian, HH Jr. (1995). Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 10(1):119–121

    Article  PubMed  CAS  Google Scholar 

  67. Lin, H.F.; Maeda, N.; Smithies, O.; Straight, D.L. and Stafford, D.W. (1997) A coagulation factor IXdeficient mouse model for human hemophilia B. Blood 90(10): 3962–3966.

    PubMed  CAS  Google Scholar 

  68. Giles, A.R.; Tinlin, S. and Greenwood, R. (1982) A canine model of hemophilic (factor VIII:C deficiency) bleeding. Blood 60(3): 727–730.

    PubMed  CAS  Google Scholar 

  69. Evans, J.P.; Brinkhous, K.M.; Brayer, G.D.; Reisner, H. and High, K.A. (1989) Canine hemophilia B resulting from a point mutation with unusual consequences. Proc. Natl. Acad. Sci. USA 86(24): 10095–10099.

    PubMed  CAS  Google Scholar 

  70. Wang, L.; Zoppe, M.; Hackeng, T.M.; Griffin, J.H.; Lee, K.F. and Verma, I.M. (1997) A factor IXdeficient mouse model for hemophilia B gene therapy. Proc. Natl. Acad. Sci. USA 94(21): 11563–11566.

    Article  PubMed  CAS  Google Scholar 

  71. Kay, M. and High, K. (1999) Gene therapy for the hemophilias. Proc. Natl. Acad. Sci. USA 96: 9973–9975.

    Article  PubMed  CAS  Google Scholar 

  72. Wang, L.; Takabe, K.; Bidlingmaier, S.M.; Ill, C.R. and Verma, I.M. (1999) Sustained correction of bleeding disorder in hemophilia B mice by gene therapy. Proc. Natl. Acad. Sci. USA 96(7): 3906–3910.

    Article  PubMed  CAS  Google Scholar 

  73. Garcia-Martin, C.; Chuah, M.K.; Van Damme, A.; Robinson, K.E.; Vanzieleghem, B.; Saint-Remy, J.M.; Gallardo, D.; Ofosu, F.A.; Vandendriessche, T. and Hortelano, G. (2002) Therapeutic levels of human factor VIII in mice implanted with encapsulated cells: potential for gene therapy of haemophilia A. J. Gene Med. 4(2): 215–223.

    Article  PubMed  Google Scholar 

  74. Saller, R.M.; Indraccolo, S.; Coppola, V.; Esposito, G.; Stange, J.; Mitzner, S.; Amadori, A.; Salmons, B. and Gunzburg, W.H. (2002) Encapsulated cells producing retroviral vectors for in vivo gene transfer. J. Gene Med. 4(2): 150–160.

    Article  PubMed  Google Scholar 

  75. Prakash, S. and Chang, T.M. (1996). Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat. Med. 2(8): 883–887.

    Article  PubMed  CAS  Google Scholar 

  76. Birney, E.; Bateman, A.; Clamp, M.E. and Hubbard, T.J. (2001) Mining the draft human genome. Nature 409: 827–828.

    Article  PubMed  CAS  Google Scholar 

  77. Dautzenberg, H.; Schuldt, U.; Grasnick, G.; Karle, P.; Muller, P.; Lohr, M.; Pelegrin, M.; Piechaczyk, M.; Rombs, K.V.; Gunzburg, W.H.; Salmons, B. and Saller, R.M. (1999) Development of cellulose sulfatebased polyelectrolyte complex microcapsules for medical applications. Ann. NY Acad. Sci. 875: 46–63.

    Article  PubMed  CAS  Google Scholar 

  78. Lahooti, S. and Sefton, M.V. (2000) Effect of an immobilization matrix and capsule membrane permeability on the viability of encapsulated HEK cells. Biomaterials 21(10): 987–995.

    Article  PubMed  CAS  Google Scholar 

  79. Joki, T.; Machluf, M.; Atala, A.; Zhu, J.; Seyfried, N.T.; Dunn, I.F.; Abe, T.; Carroll, R.S. and Black, P.M. (2001) Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat. Biotechnol. 19(1): 35–39.

    Article  PubMed  CAS  Google Scholar 

  80. Weber, M.; Steinert, A.; Jork, A.; Dimmler, A.; Thurmer, F.; Schutze, N.; Hendrich, C. and Zimmerman, U. (2002) Formation of cartilage matrix proteins by BMP-transfected murine mesenchymal stem cells encapsulated in a novel class of alginates. Biomaterials 23(9): 2003–2013.

    Article  PubMed  CAS  Google Scholar 

  81. Rokstad, A.M.; Holtan, S.; Strand, B.; Steinkjer, B.; Ryan, L.; Kulseng, B.; Skjak-Braek, G. and Espevik, T. (2002) Microencapsulation of cells producing therapeutic proteins: optimizing cell growth and secretion. Cell Transplant. 11(4): 313–324.

    PubMed  Google Scholar 

  82. Naganawa, Y.; Ohsugi, K.; Kase, R.; Date, I.; Sakuraba, H. and Sakuragawa, N. (2002) In vitro study of encapsulation therapy for Fabry disease using genetically engineered CHO cell line. Cell Transplant. 11(4): 325–329.

    PubMed  CAS  Google Scholar 

  83. Date, I.; Shingo, T.; Yoshida, H.; Fujiwara, K.; Kobayashi, K. and Ohmoto, T. (2000) Grafting of encapsulated dopamine-secreting cells in Parkinson’s disease: long-term primate study. Cell Transplant. 9(5): 705–709.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology & Molecular Medicine, McMaster University, Hamilton, Ontario, L8N 3Z5, Canada

    Gonzalo Hortelano

Authors
  1. Gonzalo Hortelano
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Belgrade, Belgrade, Serbia and Montenegro

    Viktor Nedović

  2. Free University of Brussels, Brussels, Belgium

    Ronnie Willaert

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer

About this chapter

Cite this chapter

Hortelano, G. (2005). Gene Therapy Using Encapsulated Cells. In: Nedović, V., Willaert, R. (eds) Applications of Cell Immobilisation Biotechnology. Focus on Biotechnology, vol 8B. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3363-X_13

Download citation

Publish with us

Policies and ethics

Search

Navigation